Our research enterprise is organized into two main Centers, focused on cancer research and vaccine and immunotherapy development. The Centers operate in a highly interdisciplinary environment and benefit from several core facilities that provide state-of-the-art technical support. Investigators with common research interests are also organized into additional research groups that reflect their shared focus.
A culture that fosters collaboration is key to Wistar's success as a discovery engine. The Institute takes a "team science" approach to its research endeavors to advance the process of translating basic research discoveries to clinical therapies.
Creating Effective Solutions to Address the Coronavirus Pandemic
Wistar has a strong history of addressing infectious disease outbreaks with urgency and discoveries that make an impact on global health. Wistar researchers are committed to assist the greater scientific community in finding a solution to curb the ongoing pandemic by leveraging their expertise in new technologies.
The Coronavirus Discovery Fund was created in response to the novel coronavirus outbreak (COVID-19). Learn more about areas of concentration, projects scope and ways to support our efforts.
Wistar is part of the global scientific community mobilized to fight this threat and a member of the Penn Center for Coronavirus and Emerging Pathogens.
The mission of The Wistar Institute Cancer Center is to merge basic, translational and disease-relevant cancer research in a single scientific continuum that produces advances in cancer prevention, diagnosis and therapy.
Vaccine & Immunotherapy Center
The Institute's work in immunology, virology, and other research disciplines improve public health around the globe through the creation of new vaccines for some of the most dangerous and widespread diseases. Building on the most recent advances in vaccine and immunotherapy technology, the Center also develops novel immunotherapeutic strategies for the treatment of cancer.